Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Frozen FMT for Recurrent CDI
NCT02394275Phase 2Terminated
- Sponsor
- McMaster University
- Start
- Mar 2014
- Primary completion
- Sep 2016
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of allogeneic fecal microbiota in Clostridioides difficile infection (CDI), sponsored by McMaster University. Primary endpoint: No Recurrence of CDI-related Diarrhea at 13 weeks. Started Mar 2014; status: terminated.
02
Drugs
allogeneic fecal microbiota
03
Conditions
Clostridioides difficile infection (CDI)
Beyond the preview
Go deeper on NCT02394275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02394275.